HERE0:5

FirstQuarter

Merck Announces First-Quarter 2015 Financial Results
www.fiercepharma.com

The company announced the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) of JANUVIA (sitagliptin), a medicine that helps lower blood sugar levels in adults with type 2 diabetes, achieved its primary endpoint of non-inferiority for …

11
Like
Save